Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin B pharmacokinetics and safety in critically ill elderly patients
ChiCTR2300073896Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of polymyxin B in Gram-negative bacterial infection and Infection (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: AUCss, 24h and Css, avg. Started Dec 2021; status: recruiting.
02
Drugs
polymyxin B
03
Conditions
Gram-negative bacterial infectionInfection
Beyond the preview
Go deeper on ChiCTR2300073896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073896.